Last reviewed · How we verify
PEMIROLAST
At a glance
| Generic name | PEMIROLAST |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1999 |
Approved indications
Common side effects
Key clinical trials
- Pemirolast in Allergen Challenge (PEMAG) (PHASE2)
- Safety and Efficacy of CRD007 in Adult Asthma Subjects (PHASE2)
- RSPR-007 Mannitol Challenge Trial (PHASE2)
- Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PEMIROLAST CI brief — competitive landscape report
- PEMIROLAST updates RSS · CI watch RSS